Navigation Links
The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies
Date:8/29/2014

Boston, MA (PRWEB) August 29, 2014

Due to a misstatement posted by the Family Resource Council (FRC) last week, the Adult Stem Cell Technology Center, LLC (ASCTC) was reported as an entity accepting donations to support stem cell therapy research that might benefit ALS patients. Because of ASCTC's exclusive focus on developing adult stem cells for new stem cell technologies and therapeutic applications, FRC listed ASCTC as one of several alternatives for ALS Ice Bucket Challenge donors who wish not to support research that requires the death of human embryos or fetal abortions.

After authorizing the listing by FRC, ASCTC's Director James Sherley states that he was surprised by suddenly receiving a number of communications from individuals inquiring how to donate to ASCTC. A look at the FRC posting explained the contacts. Inadvertently, ASCTC had been indicated as an agency that received donations for stem cell research. After ASCTC notified FRC staff of the mistake, the posting was immediately corrected. Since the correction, Director Sherley reports that the number of donation contacts has decreased, but not stopped completely.

In addition to the FRC correction, the ASCTC now responds to donation inquiries with the following statement:

“Thank you for your interest in donating to ASCTC to support its development efforts in adult stem cell technologies. If your query was motivated by a recent Family Resource Council (FRC) notice, unfortunately, the notice posted by FRC was mistaken in its 'donate' message and did not adequately indicate that ASCTC is a for-profit company. Therefore, there is no means by which to 'donate' to the company.
     At my request, FRC has now corrected the posting. It is possible to invest in ASCTC commercial development of technologies for producing and quantifying human adult stem cells for drug development and therapeutics. However, this was not the intent of the FRC notice. Its purpose was to make the public aware of all the entities, not-for-profit or for-profit, engaged in developing stem cell technologies, potentially relevant to finding a cure for ALS, that do not use human embryonic stem cells.
     Please, accept my apologies for the miscommunication; and thank you for your good will in supporting ethical research to help others suffering from devastating illnesses like ALS.

Sincerely,

James L. Sherley
Director
ASCTC, LLC”

Director Sherley observed, “The best thing about this unfortunate situation is that I have had the pleasure of communicating with some very caring people…and that is quite inspiring!”
*************************************************************************************************************
The Adult Stem Cell Technology Center, LLC (ASCTC) is a Massachusetts life sciences company established in September 2013. ASCTC Director and founder, James L. Sherley, M.D., Ph.D. is the foremost authority on the unique properties of adult stem cells. The company’s patent portfolio contains biotechnologies that solve the two main technical problems – production and quantification – that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing iPSCs. Currently, ASCTC is employing its technological advantages to pursue commercialization of mass-produced therapeutic human liver cells and facile assays that are early warning systems for drug candidates with catastrophic toxicity due to adverse effects against adult tissue stem cells.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12128093.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. American Botanical Council Publishes a History of Adulteration
2. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
3. Nonprofit Consortium Publishes Review of Skullcap Adulteration
4. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
5. Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
6. NIH media availability: Protein linked to increased risk of heart failure and death in older adults
7. StemGenex to Launch Adult Stem Cell-Based Therapy to Relieve COPD Symptoms
8. Some Bilberry Fruit Extracts Adulterated, says Nonprofit Research Consortium
9. Thackray Crane Rental Prepares Visible Memorial For The Newtown, Connecticut Children and Adults Who Were Ambushed and Taken Away From Their Families
10. Adult Stem Cell Therapy Breakthrough Leads to Crowd Funding Campaign on Indiegogo.com for Centagen, Inc.
11. Island Abbey Foods Ltd™ Now Offering New Honibe® Honey Lozenges™ Flavour Variations for Both Adults and Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a go-getter type of ... growth is accounted to two main factors. The first is the amazing customer ... vendors supplying FireflySci products all around the world. , 2016 was a tremendous sales ...
(Date:1/19/2017)... BD (Becton, Dickinson and Company) (NYSE: BDX ... host a live webcast of its Annual Meeting of Shareholders on ... The webcast can be accessed from the BD corporate website at ... 31, 2017. ... About BD BD is a global medical technology company that ...
(Date:1/18/2017)... HACKENSACK, N.J. , Jan. 18, 2017   ... leading the fight to end Duchenne muscular dystrophy ... awarded to the New Jersey Institute of Technology (NJIT) ... ongoing exploration of robotic technology to assist ... study to incorporate NJIT,s technology – an embedded computer, ...
(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, which creates ... has submitted a 510(k) to the FDA, requesting clearance of the MyoCycle Home ... stimulation (FES) technology. , The submission marks a major milestone for the ...
Breaking Biology Technology:
(Date:12/16/2016)... -- The global wearable medical device market, in terms of value, ... 5.31 billion in 2016, at a CAGR of 18.0% during the ... ... medical devices, launch of a growing number of smartphone-based healthcare apps ... providers, and increasing focus on physical fitness. Furthermore, ...
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition ... Service, Application Area, End User, And Region - Global Forecast to 2021", published ... in 2016 to USD 36.07 Billion by 2021, at a Compound Annual Growth ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):